1. Pneumology, ENT and Dermatology,
2. Imaging Platform (2IP),
3. Laboratory of Respiratory Diseases & Thoracic Surgery, Department of Chronic Diseases and Metabolism, and
4. Applied Molecular Technologies Center,
5. Department of Pathology, University of Giessen and Marburg Lung Center, Justus-Liebig University Giessen, German Center for Lung Research, Giessen, Germany;
6. Louvain Center for Toxicology and Applied Pharmacology, and
7. Clinical Department of Respiratory Diseases, University Hospitals – University of Leuven, Leuven, Belgium;
8. Department of Biochemistry and Molecular Biology and
9. Division of Critical Care and
10. Division of Pulmonary and Sleep Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas;
11. Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France;
12. Département de Pathologie and
13. INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France;
14. UMR_S 1166-ICAN, INSERM, Sorbonne Université, Paris, France;
15. Cardiovascular Research Unit, Institute of Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium;
16. Assistance Publique–Hôpitaux de Paris, Centre de Référence de l’Hypertension Pulmonaire, Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France;
17. Laboratoire CarMeN, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, Pierre-Bénite and Bron, France; and
18. Département de Pneumologie, Cliniques Universitaires St-Luc, Brussels, Belgium